199 related articles for article (PubMed ID: 37538541)
1. Potential global loss of life expected due to COVID-19 disruptions to organised colorectal cancer screening.
Worthington J; van Wifferen F; Sun Z; de Jonge L; Lew JB; Greuter MJE; van den Puttelaar R; Feletto E; Lansdorp-Vogelaar I; Coupé VMH; Ein Yong JH; Canfell K;
EClinicalMedicine; 2023 Aug; 62():102081. PubMed ID: 37538541
[TBL] [Abstract][Full Text] [Related]
2. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.
de Jonge L; Worthington J; van Wifferen F; Iragorri N; Peterse EFP; Lew JB; Greuter MJE; Smith HA; Feletto E; Yong JHE; Canfell K; Coupé VMH; Lansdorp-Vogelaar I;
Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):304-314. PubMed ID: 33548185
[TBL] [Abstract][Full Text] [Related]
3. Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study.
van Wifferen F; de Jonge L; Worthington J; Greuter MJE; Lew JB; Nadeau C; van den Puttelaar R; Feletto E; Yong JHE; Lansdorp-Vogelaar I; Canfell K; Coupé VMH;
J Med Screen; 2022 Jun; 29(2):72-83. PubMed ID: 35100894
[TBL] [Abstract][Full Text] [Related]
4. Validation of Microsimulation Models against Alternative Model Predictions and Long-Term Colorectal Cancer Incidence and Mortality Outcomes of Randomized Controlled Trials.
Lew JB; Greuter MJE; Caruana M; He E; Worthington J; St John DJ; Macrae FA; Feletto E; Coupé VMH; Canfell K
Med Decis Making; 2020 Aug; 40(6):815-829. PubMed ID: 32845232
[No Abstract] [Full Text] [Related]
5. Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study.
Lew JB; St John DJB; Xu XM; Greuter MJE; Caruana M; Cenin DR; He E; Saville M; Grogan P; Coupé VMH; Canfell K
Lancet Public Health; 2017 Jul; 2(7):e331-e340. PubMed ID: 29253458
[TBL] [Abstract][Full Text] [Related]
6. COVID-related disruptions to colorectal cancer screening, diagnosis, and treatment could increase cancer Burden in Australia and Canada: A modelling study.
Worthington J; Sun Z; Fu R; Lew JB; Chan KKW; Li Q; Eskander A; Hui H; McLoughlin K; Caruana M; Peacock S; Yong JHE; Canfell K; Feletto E; Malagón T
PLoS One; 2024; 19(4):e0296945. PubMed ID: 38557758
[TBL] [Abstract][Full Text] [Related]
7. Modelling the impact of the coronavirus pandemic on bowel cancer screening outcomes in England: A decision analysis to prepare for future screening disruption.
Mandrik O; Chilcott J; Thomas C
Prev Med; 2022 Jul; 160():107076. PubMed ID: 35526674
[TBL] [Abstract][Full Text] [Related]
8. Projected long-term effects of colorectal cancer screening disruptions following the COVID-19 pandemic.
Nascimento de Lima P; van den Puttelaar R; Hahn AI; Harlass M; Collier N; Ozik J; Zauber AG; Lansdorp-Vogelaar I; Rutter CM
Elife; 2023 May; 12():. PubMed ID: 37129468
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Colon Cancer Screening - Is It Time Yet?
Bhurgri H; Samiullah S
J Coll Physicians Surg Pak; 2017 Jun; 27(6):327-328. PubMed ID: 28689518
[TBL] [Abstract][Full Text] [Related]
11. Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment.
Worthington J; Lew JB; Feletto E; Holden CA; Worthley DL; Miller C; Canfell K
PLoS One; 2020; 15(2):e0227899. PubMed ID: 32012174
[TBL] [Abstract][Full Text] [Related]
12. Realized impact of COVID-19 related disruptions on the National Bowel Cancer Screening Program.
Irwin MP; Dutta T; Jambor MA; Morgan MJ; Turner CE; Liang Y
ANZ J Surg; 2024 Feb; ():. PubMed ID: 38345127
[TBL] [Abstract][Full Text] [Related]
13. Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management: cross-sectional survey of healthcare professionals.
El-Zein M; Ali R; Farah E; Botting-Provost S; Franco EL;
Elife; 2023 Jun; 12():. PubMed ID: 37377399
[TBL] [Abstract][Full Text] [Related]
14. The impact of COVID-19 pandemic in the diagnosis and management of colorectal cancer patients.
Domper-Arnal MJ; Hijos-Mallada G; Lanas Á
Therap Adv Gastroenterol; 2022; 15():17562848221117636. PubMed ID: 36035306
[TBL] [Abstract][Full Text] [Related]
15. Unequal Recovery in Colorectal Cancer Screening Following the COVID-19 Pandemic: A Comparative Microsimulation Analysis.
de Lima PN; van den Puttelaar R; Hahn AI; Harlass M; Collier N; Ozik J; Zauber AG; Lansdorp-Vogelaar I; Rutter CM
medRxiv; 2022 Dec; ():. PubMed ID: 36597528
[TBL] [Abstract][Full Text] [Related]
16. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
17. Long-term benefits for lower socioeconomic groups by improving bowel screening participation in South Australia: A modelling study.
Lal A; Gao L; Tan E; McCaffrey N; Roder D; Buckley E
PLoS One; 2022; 17(12):e0279177. PubMed ID: 36542644
[TBL] [Abstract][Full Text] [Related]
18. Impact and Recovery from COVID-19-Related Disruptions in Colorectal Cancer Screening and Care in the US: A Scenario Analysis.
van den Puttelaar R; Lansdorp-Vogelaar I; Hahn AI; Rutter CM; Levin TR; Zauber AG; Meester RGS
Cancer Epidemiol Biomarkers Prev; 2023 Jan; 32(1):22-29. PubMed ID: 36215205
[TBL] [Abstract][Full Text] [Related]
19. The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada.
Yong JH; Mainprize JG; Yaffe MJ; Ruan Y; Poirier AE; Coldman A; Nadeau C; Iragorri N; Hilsden RJ; Brenner DR
J Med Screen; 2021 Jun; 28(2):100-107. PubMed ID: 33241760
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer screening: the time to act is now.
Brenner H; Stock C; Hoffmeister M
BMC Med; 2015 Oct; 13():262. PubMed ID: 26459270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
